PAQR8 and breast cancer: Consistent with a clinically relevant role in breast cancer, we found that PAQR8 is spontaneously upregulated and CN gained in post-therapy recurrent tumors from multiple mouse models and is associated with breast cancer progression and poor survival in patients.